Crcam Ille Et Vilaine (XPAR:CIV) Research & Development: €0.0 Mil (TTM As of Dec. 2025)


XPAR:CIV Crcam Ille Et Vilaine XPAR:CIV
48 GF Score
Price €124.20
GF Value €63.02
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Crcam Ille Et Vilaine Research & Development?

Crcam Ille Et Vilaine XPAR:CIV -2.59% 48 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates XPAR:CIV with a GF Score™ of 48/100 and a GF Value™ of €63.02 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Crcam Ille Et Vilaine's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Crcam Ille Et Vilaine  (XPAR:CIV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Crcam Ille Et Vilaine Research & Development Related Terms

Crcam Ille Et Vilaine Research & Development Historical Data

* Premium members only.

The historical data trend for Crcam Ille Et Vilaine's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crcam Ille Et Vilaine Research & Development Chart

Crcam Ille Et Vilaine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Crcam Ille Et Vilaine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:CIV
48GF Score
Crcam Ille Et Vilaine XPAR:CIV
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crcam Ille Et Vilaine Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Crcam Ille Et Vilaine (XPAR:CIV) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Crcam Ille Et Vilaine and its competitors.
Is Crcam Ille Et Vilaine's Research & Development too high?
Crcam Ille Et Vilaine's current Research & Development is €0.0 Mil. Overall, Crcam Ille Et Vilaine has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crcam Ille Et Vilaine's Research & Development compare to competitors?
Crcam Ille Et Vilaine's Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Crcam Ille Et Vilaine and its competitors. Crcam Ille Et Vilaine's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crcam Ille Et Vilaine stock overvalued right now?
Based on GuruFocus' analysis, Crcam Ille Et Vilaine (XPAR:CIV) is currently considered Significantly Overvalued. The stock's GF Value™ is €63.02, compared to a current price of €124.20 — trading 97.1% above its estimated fair value. The current Research & Development is €0.0 Mil. Crcam Ille Et Vilaine's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Crcam Ille Et Vilaine (XPAR:CIV), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crcam Ille Et Vilaine (XPAR:CIV) Overvalued in 2026?

Based on GuruFocus' analysis, Crcam Ille Et Vilaine stock appears to be overvalued. The current stock price of €124.20 is trading 97.1% above its estimated GF Value™ of €63.02. GuruFocus considers Crcam Ille Et Vilaine to be Significantly Overvalued.

Key valuation signals for XPAR:CIV:

  • Research & Development: €0.0 Mil
  • GF Value™: €63.02 vs. price of €124.20 (97.1% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the XPAR:CIV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crcam Ille Et Vilaine Business Description

Address 45 boulevard de la Liberte CS 64017, Rennes, FRA, 35000
Crcam Ille Et Vilaine Formerly Crédit Agricole d'Ille-et-Vilaine is involved in providing banking services in France. The company offers savings, mortgages, loans, and account management services, as well as insurance products. It serves individuals, professionals, farmers, companies, and associations.
48GF Score

Get the complete analysis for XPAR:CIV

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€124.20
Price
€63.02
GF Value